Effectiveness of mRNA, protein subunit vaccine and viral vectors vaccines against SARS-CoV-2 in people over 18 years old: a systematic review.

Cristian SandovalDaniela GuerreroJoham MuñozKarina GodoyVanessa Souza-MelloJorge Farías

Published in: Expert review of vaccines (2022)

Our results suggest that new vaccinations could have more than 90% efficacy against SARS-CoV-2, regardless of the technology used. Furthermore, adverse reactions go from mild to moderate, and good immunogenicity can be observed for all vaccine types.

Keyphrases

sars cov
respiratory syndrome coronavirus
randomized controlled trial
binding protein
systematic review
emergency department
amino acid
gene therapy